Cerevance的动态

The UNSW Precision Care Initiative has recently introduced a new?Online Referral Form?to?facilitate and streamline referrals to the Precision Care Clinic at Prince of Wales Hospital (South Eastern Sydney Local Health District (SESLHD)),?Randwick. The Precision Care Clinic multidisciplinary team (MDT) aims to provide context-specific oncology patient care guidance and support in terms of: - Interpreting and reviewing?molecular results to strengthen clinical decision-making around treatment, diagnosis, and management options - Identifying and prioritising?targeted therapy options +/- clinical trials - Assessing?potential germline variants and facilitating appropriate clinical validation?testing More information on WHO to refer, and HOW to refer, can be found here: https://lnkd.in/gPBpPR3i #health #innovation #precisionmedicine #oncology

Communication can always be improved. Communication gaps exist between hematology-oncology professionals and patients. I bet these consequences are driving worse outcomes: ·??????Increased patient anxiety around therapy due to unknowns ·??????Patient distrust of provider(s) due to lack of clear explanations ·??????Clinical trial participation is low (referenced below for more detail) ·??????Patients hold off on reporting “expected” side effects that can indicate more serious issues (e.g. diarrhea or altered breathing with Keytruda) ·??????Inability for patients to differentiate between immunotherapy, chemotherapy, targeted therapy, etc. – critical info to managing care ·??????Non-adherence and discontinuations are more likely ·??????I’m sure there are more… Clinical could learn strategies from sales/marketing about how to communicate differently with patients in order to better stick these ideas & concepts around treatment. Let’s progress. How are you improving patient communication? Share! #Oncology #PatientEngagement #ClinicalCommunication #HealthLiteracy Reference review encouraged for further detail: Parker ND, Murphy MC, Eggly S, Weiss ES, Amin TB, Wollney EN, Wright KB, Friedman DR, Sae-Hau M, Sitlinger A, Staras SAS, Szumita L, Cooks E, Bylund CL. Educating Hematology-Oncology Fellows About How to Communicate with Patients About Clinical Trials: A Needs Assessment. J Med Educ Curric Dev. 2024 Aug 5;11:23821205241269376. doi: 10.1177/23821205241269376. PMID: 39104855; PMCID: PMC11299213.

A Reminder to Medical Professionals, Clinical Teams, and Industry Experts: Register Today!" This is your opportunity to join a critical discussion that will shape the future of cholangiocarcinoma care. Bringing together world-class experts, this event provides cutting-edge insights and strategies designed to improve outcomes for patients with this aggressive cancer. Who is this event for? ?? Medical professionals in oncology, gastroenterology, hepatology, and related fields. ?? Surgeons specialising in hepatobiliary and pancreatic procedures. ?? Clinical nurses and patient healthcare teams. ?? Pathologists and diagnostics researchers. ?? Pharmaceutical and biotech industry leaders. ?? Interventional specialists, including ERCP and advanced endoscopic teams. Why attend? ?? Stay ahead with the latest advancements in treatment pathways and precision care. ?? Collaborate with global leaders in cholangiocarcinoma and oncology research. ?? Be part of the movement driving transformational change for patients and their outcomes. Event Details: ?? Date: 28th January ?? Time: 5:30 to 6:30 pm AEDT ?? Location: Online (Zoom) ?? Details & Register https://lnkd.in/gGHr_Eku Your expertise and voice are vital. Please share this with colleagues, networks, and anyone in the healthcare or research community who can contribute to this important cause. Together, we can drive meaningful change. #cholangiocarcinomaAustralia #Cholangiocarcinoma #BileDuctCancer #NextGenerationSequencing #MolecularProfiling #ClinicalTrials #Immunotherapy #CholangiocarcinomaTreatments

NeuroTherapia, Inc., a Cleveland Clinic Innovations portfolio company, has raised $12.3M in the first close of its series B financing! ?? NeuroTherapia, Inc. is a clinical-stage company focused on developing treatments for neurodegenerative diseases; this milestone reflects the groundbreaking work the company is doing in the field of neurotechnology. This significant funding round will accelerate their innovative efforts to support the clinical development of NTRX-07, an orally available cannabinoid receptor agonist, for the treatment of Alzheimer's disease. "We were pleased with the Phase 1b trial results that demonstrated a trend toward cognitive benefits in Alzheimer's disease and wanted to continue its development as rapidly as possible," commented Joseph Rich, JD, MBA, Senior Director, Governance, Grants, and Policies, Cleveland Clinic Innovations, and lead investor representative in this financing. "We believe that the Company's planned Phase 2a trial has the potential to not only demonstrate the ability of NTRX-07 to inhibit neuroinflammation, but it could also lead to an improvement in biomarkers of cognitive function in patients with Alzheimer's disease." Congratulations to the entire NeuroTherapia team on this impressive achievement! We look forward to seeing your continued success and impact in the neurotherapeutics space. https://hubs.li/Q02KRB110 #ClevelandClinic #Innovation #NeuroTherapia #HealthcareInnovation #SeriesBFunding #Neurotechnology #AlzheimersDisease Cleveland Clinic #ClevelandClinicInnovations

Hello LinkedIn! Wow, the week has been busy and it's hard to highlight every single development in the market, so I summarised the newest ones. I hope everyone who attended HLTH Europe this week had a great time! Seems like it was a productive one. Some of the main highlights include: - Polish MedTech Startup Quantum Innovations raised €10M!! - Johnson & Johnson MedTech launched a digital surgical ecosystem. - MHRA issued transparency guidance for machine-learning medical devices. - OncoBeta - epidermal radioisotope therapy's Rhenium-SCT skin cancer therapy rolled out in the Madrid clinic. - Akili has received FDA approval for the first ADHD treatment game. - AEYE Health and Optomed Plc, will launch an autonomous diabetic retinopathy screening tool, Aurora AEYE. And finally, researchers in the US are developing a new range of wound care technologies, including smart bandages that would automatically sense and respond to changing conditions inside a wound. Catching up with you all next week! #medtechwithindre #digitalhealth #medicaldevices #medtech #healthinnovation #lifesciences

?? Enhancing Clinician Education with MultiM3d ?? Join Alison McKinney, Chief Nursing Officer at WMUK (Waldenstrom's macroglobulinaemia UK), as she explores how MultiM3d is transforming clinician education about Waldenstr?m's Macroglobulinemia, a rare form of B cell lymphoma. Despite being a small charity, WMUK leverages MultiM3d to provide accessible and comprehensive educational resources to healthcare professionals. In this short video, Alison discusses: ?? The impact of MultiM3d on reaching a broad audience of clinicians ?? How features like automatic recording of learning time, CPD, and user feedback enhance the educational experience ?? The benefits of a Netflix-style interface for seamless learning Discover how WMUK (Waldenstrom's macroglobulinaemia UK) is overcoming resource limitations to educate clinicians effectively! #pharma, #pharmadigital, #pharmamarketing, #HCPengagement, #DigPharm, #beyondthepill, #Pharmamktg

New Free Webinar ?? This webinar will provide a comprehensive introduction to the lung transplant population. Learners will gain insight into indications for lung transplant, the lung transplant selection process, risk factors that place this population at increased risk of dysphagia, and evidence based principles of dysphagia management for lung transplant recipients. We will highlight the role of the SLP in the lung transplant team both during the post operative course as well as the role of prehabilitation for prospective lung transplant candidates. Learning Objectives 1) Describe the incidence of post op dysphagia in this population and identify risk factors increasing their risk of dysphagia/aspiration. 2) Describe the role of the SLP within the lung transplant team. 3) Describe an evidence based post op pathway for dysphagia management in lung transplant patients. This webinar will be approximately 60 minutes in length which will include Q&A. For more info or to register: https://lnkd.in/eygkhFBb #lungtransplant #pulmonary #respiratorytherapy #dysphagia #medslp

Pain Management course (online) for oncologists begins on 12 September 2024. Apply now and secure your seat. Objective of this course: To enable oncologists in practical management of pain & related communication. Eligible Participants: Oncologists (Medical, Pediatric, Radiation, Clinical, Surgical) Topics: 1. Introduction to pain mechanism & management 2. Proper assessment of pain and types of pain 3. Introduction to communication in the context of Pain 4. Introduction to WHO ladder & non-opioids 5. Adjuvant analgesics 6. Opioids (Tramadol, Morphine, Fentanyl, Methadone) 7. RMI status – best practices 8. Opioids: Case-based learnings #palliativemedicine #oncology #oncologist #painrelief #symptommanagement #painmanagement

In a world of rapid advancements, staying ahead is key. ONS’s Genomics Roadmap for Nurses is designed to equip you with the genomic knowledge needed in precision oncology. From foundational learning to clinical decision support, this four-step guide equips you with the skills to bring precision oncology to life in your practice. Transform your knowledge into actionable patient care with ONS’s Genomics Roadmap for Nurses now. https://bit.ly/3MJeB0D

Very useful information!